Rankings
▼
Calendar
MLYS Q4 2024 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
MLYS
Mineralys Therapeutics, Inc.
$2B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$52M
Net Income
-$49M
EPS (Diluted)
$-0.98
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$67M
Free Cash Flow
-$67M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$206M
Total Liabilities
$15M
Stockholders' Equity
$191M
Cash & Equivalents
$114M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$52M
-$28M
-86.8%
Net Income
-$49M
-$24M
-100.7%
← FY 2024
All Quarters
Q1 2025 →